Table 1.
Characteristics of participants by country
| Characteristic | Canada (n = 941) | Ireland (n = 96) |
|---|---|---|
| Number (%) | Number (%) | |
| Gender | ||
| Men | 740 (79%) | 71 (74%) |
| Women | 159 (17%) | 23 (24%) |
| Transgender | 19 (2%) | 2 (2%) |
| Two-spirited | 15 (2%) | – |
| Missing | 8 (1%) | – |
| Median age in years (25–75th percentile) | 48 (39–54) | 41 (34–48) |
| 50 years or older | 405 (43%) | 22 (23%) |
| Median time since HIV diagnosis in years (25–75th percentile) | 13 (6–21) | 9 (4–14) |
| Taking antiretroviral therapy | 851 (90%) | 84 (88%) |
| Undetectable viral load (< 40 copies/mL)b | 572 (67%) | 41 (85%) |
| Employment status (full-time or part-time) | 350 (37%) | 52 (54%) |
| Median number of concurrent health conditions (25–75th percentile) | 3 (1–6) | 1 (0–3) |
| Living with ≥ 2 concurrent health conditions in addition to HIV | 518 (72%) | 39 (41%) |
| Common concurrent health conditionsa | ||
| Mental health condition | 392 (42%) | 18 (19%) |
| Muscle pain | 308 (33%) | 21 (22%) |
| Joint pain | 282 (30%) | 22 (23%) |
| Addiction | 248 (26%) | 9 (9%) |
| Neurocognitive decline | 209 (22%) | 11 (12%) |
| Hepatitis Cc | 95 (10%) | 21 (22%) |
| Self-rated health status ‘very good’ | 274 (29%) | 34 (35%) |
Number of participants: n = 1037; Not all characteristics add to the total n due to missing responses
aConcurrent health conditions experienced by ≥ 20% of respondents in either sample
bBased on number of participants who confirmed they were taking antiretroviral therapy; out of 851 (Canadian) and 48 (Irish) samples respectively. Among Canadian sample, 44 (5%) could not remember or did not know their viral load
cIrish sample recruited from an HIV-Hep-C co-infection clinic